Company Research Report: PolyNovo Limited
Company Overview
Name
PolyNovo Limited
Mission of the Company
To innovate and bring disruptive technologies to market by partnering with the best minds to improve patient outcomes and reimagine the standard of care.
Year of Founding
No information is available.
Founder(s)
No information is available.
Key People in the Company
- Swami Raote - Chief Executive Officer
- Jan Gielen - Chief Financial Officer
- Lior Harel - General Counsel and Company Secretary
- Dr. David McQuillan - Chief Technical and Scientific Officer
- Ahmed Hassan - Director of Operations
- Dr. Joseph Amaral - Chief Medical Officer
- Ingrid Anderson - Chief People Officer
- Ed Graubart - President, North America
- David Morris - President, Asia Pacific
Headquarters
Melbourne, Australia
Number of Employees
No information is available.
Revenue
No information is available.
What is the Company Known For
PolyNovo is known for its innovative medical devices utilizing the patented bioabsorbable polymer technology NovoSorb®.
Products
NovoSorb® Technology
High-Level Description
A family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers are designed for biocompatibility and flexibility, aiding in tissue repair before biodegrading into biocompatible by-products.
Key Features
- Polymers with excellent biocompatibility
- Range of mechanical properties and degradation times
- Versatile formats for various product developments
- Scalable manufacturing process
- Robust in the presence of infection
- No tissue tracking required
- Can be stored at room temperature
NovoSorb® BTM (Biodegradable Temporizing Matrix)
High-Level Description
A synthetic, biodegradable, and biocompatible device designed to facilitate the growth of the dermis within a patented polyurethane matrix.
Key Features
- Sealing membrane that limits moisture loss and serves as a bacterial barrier
- Bioabsorbable open cell matrix that aids dermal reconstruction
- Designed to minimize scarring and contracture
- Cost-effective and does not require cold storage
- Available in large sizes, easy to apply with sutures or staples
- Suitable for various wound types including traumatic wounds, ulcers, and surgical wounds
Recent Developments
Recent Developments in the Company
New Products Launched
No information is available.
New Features Added to Existing Products
- NovoSorb BTM milestones span from its initial development in 2004 to achieving market access in 37 countries by 2023.
- NovoSorb BTM is now capable of integrating into the wound bed in 2-3 weeks, facilitating a robust healing process.
- The sealing membrane of NovoSorb BTM is designed for easy removal when the dermis is ready for secondary treatment.
New Partnerships
- Awarded an $11 million contract and an additional $25 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) to trial NovoSorb BTM for full-thickness burns.
- Collaboration with CSIRO and Prof. John Greenwood helped develop NovoSorb BTM.
Leadership
Extended Global Leadership Team
- Joshua Cheetham - Vice President, Research & Development
- Aurore Mulkens - Vice President, Quality Affairs
- Philip Scorgie - Chief Information Officer
Board of Directors
- David Williams - Non-executive Chairman
- Leon Hoare - Non-executive Director
- Bruce Rathie - Non-executive Director
- Dr. Robyn Elliott - Non-executive Director
- Christine Emmanuel - Non-executive Director
- Andrew Lumsden - Non-executive Director
Conclusion
PolyNovo Limited continues to focus on improving patient outcomes through innovative medical technologies, primarily leveraging their NovoSorb® polymers. With a growing global presence and significant backing for research and development, the company is well-positioned to redefine healing standards in the medical industry.
For in-depth insights into the adoption and application of NovoSorb® BTM and other novel medical devices, professionals are encouraged to contact PolyNovo directly or visit their dedicated websites and webinar series tailored for healthcare professionals.
© Copyright PolyNovo Limited 2024. All rights reserved.
